A plain-English guide to how ALS (motor neurone disease) progresses, based on the King’s clinical staging system. Understand each stage, what changes, and where treatment fits.
In short: ALS (amyotrophic lateral sclerosis) is staged by how many body regions are affected and when key milestones occur, most simply via the King’s clinical staging system. Progression rate differs greatly between people.
| Stage | What happens |
|---|---|
| Stage 1 — Symptom onset | First symptoms in one region (a limb, or speech/swallowing). Often subtle weakness, cramps or slurred speech. |
| Stage 2 — Second region involved | Symptoms spread to a second body region; weakness and functional loss become clearer. |
| Stage 3 — Third region involved | A third region is affected; mobility, speech, swallowing or breathing are increasingly impaired and more support is needed. |
| Stage 4 — Need for intervention | Stage 4a: a feeding tube (gastrostomy) for nutritional support. Stage 4b: non-invasive ventilation for respiratory support. Either marks advanced disease. |
Source: Roche JC et al., King’s College ALS clinical staging; also the MiToS system. Assessed by a neurologist. Staging is a clinical assessment — only a qualified specialist can stage your condition.
Conventional, stage-appropriate treatment is the foundation for ALS (motor neurone disease). Stem-cell therapy is investigational for this condition — not an approved cure. For an honest, sourced look at the evidence, cost and open trials, see stem cell therapy for ALS (Motor Neurone Disease) and what the success-rate data really shows.
ALS (motor neurone disease) is typically described in 4 stages using the King’s clinical staging system. The stages chart how the condition progresses; the pace varies a lot between individuals.
The most advanced stage is “Need for intervention” — Stage 4a: a feeding tube (gastrostomy) for nutritional support. Stage 4b: non-invasive ventilation for respiratory support. Either marks advanced disease.
Stem-cell therapy for ALS (Motor Neurone Disease) is investigational, not an approved cure — see our honest, sourced overview of stem cell therapy for ALS (Motor Neurone Disease) (evidence, cost and trials) before considering it.
GMP-сертифицированная регенеративная медицина в сердце ЕС — от €3 000–8 000, доля от цен США или Германии. Индивидуальные протоколы для пациентов из 50+ стран.
Бесплатная оценка врача